2nd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to the pharmaceutical industry HR 748 CARES Act - Issues related to COVID-19 relief

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
MARC LAMPKIN —
BRIAN MCKEON —
ZACHARY PFISTER —
BRIAN WILD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Natl Economic Council (NEC); White House Office

Bills named: H.R. 748 (116th)

Medical/Disease Research/Clinical Labs MED

Issues related to the pharmaceutical industry

LobbyistCovered position, as disclosed
EMILY FELDER —

Contacted: HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; White House Office; Natl Economic Council (NEC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.